CVS Health Corp., US1266501006

CVS Health stock up 0.43% at EUR 73.13 before Xetra opens

Published on 11/20/2026 at 08:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On November 16, RBC Capital Markets lowered its CVS Health price target to USD 108 from USD 113 while keeping an Outperform rating. On Xetra, the stock closed at EUR 72.82 on Thursday, November 19, 2026.

CVS Health: Key Investor Factors

  • RBC Capital Markets lowered its CVS Health price target to USD 108 from USD 113 while keeping an Outperform rating.
  • CVS Health serves customers through health benefits, pharmacy benefit management and retail pharmacy operations.
  • The planned business separation remains a strategic focus for investors.
CVS Health Corp., US1266501006, Illustration mit AI erstellt.

CVS Health stock traded at EUR 73.13 on Lang & Schwarz at 08:46 CET on Friday, November 20, 2026, 0.43 percent above the Xetra close of Thursday, November 19, at EUR 72.82.

CVS Health provides medical benefits management, pharmacy benefit management and retail pharmacy services, including prescription medicines, over-the-counter products and clinics.

On November 16, MarketScreener reported that RBC Capital Markets lowered its price target to USD 108 from USD 113 and kept its Outperform rating. The move comes as investors assess the planned separation of CVS Health businesses.

US equities are tracked through the S&P 500.

More news and analyses on CVS Health stock

Disclaimer...
en | US1266501006 | CVS HEALTH CORP. | boerse | 70539163 | bgmi